Rottneros AB (publ) (STO:RROS)
2.910
-0.090 (-3.00%)
Aug 1, 2025, 5:29 PM CET
Inozyme Pharma Market Cap
Rottneros AB has a market cap or net worth of 776.97 million as of August 1, 2025. Its market cap has decreased by -56.47% in one year.
Market Cap
776.97M
Enterprise Value
1.33B
Revenue
2.68B
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.91
Market Cap Chart
Since August 11, 1993, Rottneros AB's market cap has increased from 458.32M to 776.97M, an increase of 69.53%. That is a compound annual growth rate of 1.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 776.97M | -43.16% |
Dec 30, 2024 | 1.37B | -26.44% |
Dec 29, 2023 | 1.86B | -0.33% |
Dec 30, 2022 | 1.86B | 17.27% |
Dec 30, 2021 | 1.59B | 27.85% |
Dec 30, 2020 | 1.24B | -28.51% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Svenska Cellulosa Aktiebolaget SCA | 86.30B |
Boliden AB | 85.48B |
Holmen AB | 57.10B |
SSAB AB | 55.16B |
HEXPOL AB | 28.48B |
Billerud AB | 20.70B |
Alleima AB | 17.14B |
Gränges AB | 13.99B |